Patterns of structural recurrence in papillary thyroid cancer

World Journal of Surgery

Volumn 38, Issue 3, 2014, Pages 653-659

  Kruijff, Schelto ^a   Petersen, Japke F ^a   Chen, Paul ^a   Aniss, Ahmed M ^a   Clifton Bligh, Roderick J ^b   Sidhu, Stan B ^a   Delbridge, Leigh W ^a   Gill, Anthony J ^b   Learoyd, Diana ^b   Sywak, Mark S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARCINOMA; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; NECK DISSECTION; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; THYROID TUMOR; THYROIDECTOMY; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84894647408     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2286-0     Document Type: Article

References (30)

1. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States 1973-2002. JAMA 295:2164-2167
2. Malterling RR, Andersson RE, Falkmer S et al (2010) Differentiated thyroid cancer in a Swedish county-long-term results and quality of life. Acta Oncol 49:454-459
3. Grodski S, Cornford L, Sywak M et al (2007) Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg 77:203-208
4. Moo TA, McGill J, Allendorf J et al (2010) Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg 34:1187-1191. doi: 10.1007/s00268-010-0418-3
5. Enyioha C, Roman SA, Sosa JA (2013) Central lymph node dissection in patients with papillary thyroid cancer: a population level analysis of 14,257 cases. Am J Surg 205(6):655-661
6. Sywak M, Cornford L, Roach P et al (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000-1005
7. Hartl DM, Leboulleux S, Al Ghuzlan A et al (2012) Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg 255:777-783
8. Scheumann GF, Gimm O, Wegener G et al (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559-567. doi: 10.1007/BF00353765
9. Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524-531
10. White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895-904. doi: 10.1007/s00268-006-0907-6
11. Young A, Harari A, Smooke-Praw S et al (2013) Effect of re-operation on outcomes in papillary thyroid cancer. Surgery (submitted)
12. Giles Senyurek Y, Tunca F, Boztepe H et al (2009) The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection. Surgery 146:1188-1195
13. Kouvaraki MA, Shapiro SE, Fornage BD et al (2003) Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134:946-954
14. Choi JS, Kim J, Kwak JY et al (2009) Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. AJR Am J Roentgenol 193:871-878
15. Popadich A, Levin O, Lee JC et al (2011) A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery 150:1048-1057
16. Pacini F, Castagna MG, Brilli L, The ESMO Guidelines Working Group et al (2009) Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):143-146
17. Henry JF, Gramatica L, Denizot A et al (1998) Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 383:167-169
18. Shaha AR (2007) TNM classification of thyroid carcinoma. World J Surg 31:879-887. doi: 10.1007/s00268-006-0864-0
19. Cooper S, Doherty G, Huagen B et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
20. Zetoune T, Keutgen X, Buitrago D et al (2010) Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol 17:3287-3293
21. Hartl DM, Mamelle E, Borget I et al (2013) Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg 37:1951-1958. doi: 10.1007/s00268-013-2089-3
22. Machens A, Hinze R, Thomusch O et al (2002) Patterns of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22-28. doi: 10.1007/s00268-001-0176-3
23. Zaydfudim V, Feurer ID, Griffin MR et al (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thryroid carcinoma. Surgery 144:1070-1077
24. Caron NR, Tan YY, Ogilvie JB et al (2006) Selective modified radical neck dissection for papillary thyroid cancer - is level I, II and IV dissection always neccesary? World J Surg 30:833-840. doi: 10.1007/s00268-005-0358-5
25. Roh JL, Park JY, Park CI (2009) Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thryoid carcinoma undergoing total thyroidectomy plus central neck dissection. Cancer 115:251-258
26. Lim YS, Lee JC, Lee YS et al (2011) Lateral cervical lymph node metastases from papillary thyroid carcinoma: predictive factors of nodal metastasis. Surgery 150:116-121
27. Kim C, Bi X, Pan D et al (2013) The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid 23:575-582
28. Brown AP, Chen J, Hitchcock YJ et al (2008) The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 93:504-515
29. Kruijff S, Chen P, Aniss A et al (2013) Lowering doses of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery (accepted)
30. Schlumberger M, Catargi B, Borget I et al (2012) Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med 366:1163-1673